A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...
Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...
A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...
(Lawrenceburg, IN) – The 8th annual Cruisin’ to a Cure for ALS (Amyotrophic Lateral Sclerosis) car show in Lawrenceburg set ...
2d
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback